Striatal neurons but not nigral dopaminergic neurons in neonatal primary cell culture express endogenous functional N-methyl-D-aspartate receptors

Molecular Brain Research

Volumn 120, Issue 1, 2003, Pages 9-21

  Lui, P W ^a   Suen, K C ^a   Chan, Y S ^b   Yung, W H ^c   Yung, K K L ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Basal ganglia; Electrophysiology; Excitatory amino acid; Excitatory neurotransmission; Gene expression; Ionotropic glutamate receptor; Neostriatum; Neuronal growth and development; Patch clamp; Protein expression; Substantia nigra

Indexed keywords

MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DEATH; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOREACTIVITY; NEWBORN; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PATCH CLAMP; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0344304806     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.09.015     Document Type: Article

References (75)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of disorders of the basal ganglia. Trends Neurosci. 18:1995;63-64.
2. Allgaier C., Scheibler P., Muller D., Feuerstein T.J., Illes P. NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. Br. J. Pharmacol. 126:1999;121-130.
3. Behar T.N., Scott C.A., Greene C.L., Wen X., Smith S.V., Maric D., Liu Q.Y., Colton C.A., Barker J.L. Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. J. Neurosci. 19:1999;4449-4461.
4. Benke D., Wenzel A., Scheuer L., Fritschy J.M., Mohler H. Immunobiochemical characterization of the NMDA-receptor subunit NR1 in the developing and adult rat brain. J. Recept. Signal Transduct. Res. 15:1995;393-411.
5. Bernard V., Bolam J.P. Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor. Eur. J. Neurosci. 10:1998;3721-3736.
6. Blandini F., Greenamyre J.T., Nappi G. The role of glutamate in the pathophysiology of Parkinson's disease. Funct. Neurology. 11:1996;3-15.
7. Blandini F., Porter R.H., Greenamyre J.T. Glutamate and Parkinson's disease. Mol. Neurobiol. 12:1996;73-94.
8. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42:1995;674-683.
9. Buller A.L., Larson H.C., Schneider B.E., Beaton J.A., Morrisett R.A., Monaghan D.T. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. J. Neurosci. 14:1994;5471-5484.
10. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Cui J., Tu S., Sevarino K.A., Nakanishi N., Tong G., Lipton S.A., Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 415:2002;793-798.
11. Cheffings C.M., Colquhoun D. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits. J. Physiol. 526(Pt. 3):2000;481-491.
12. Chen Q., Reiner A. Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum. Brain Res. 743:1996;346-352.
13. Chen Q., Harris C., Brown C.S., Howe A., Surmeier D.J., Reiner A. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors. Exp. Neurol. 136:1995;212-224.
14. Chen Q., Veenman C.L., Reiner A. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience. 73:1996;715-731.
15. Chen Q., Surmeier D.J., Reiner A. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization. Exp. Neurol. 159:1999;283-296.
16. Colwell C.S., Cepeda C., Crawford C., Levine M.S. Postnatal development of glutamate receptor-mediated responses in the neostriatum. Dev. Neurosci. 20:1998;154-163.
17. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Rev. 32:2000;476-509.
18. Drach J., Gattringer C., Glassl H., Schwarting R., Stein H., Huber H. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma. Cytometry. 10:1989;743-749.
19. Frim D.M., Uhler T.A., Short M.P., Ezzedine Z.D., Klagsbrun M., Breakefield X.O., Isacson O. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. NeuroReport. 4:1993;367-370.
20. Gasic G.P., Hollmann M. Molecular neurobiology of glutamate receptors. Annu. Rev. Physiol. 54:1992;507-536.
21. Gerfen C.R., Wilson C.J. The basal ganglia. Swanson L.W., Bjorklund A., Hofelt T. Handbook of Chemical Neuroanatomy. Integrated Systems of the CNS. vol. 12:1996;371-468 Elsevier, Amsterdam. Part 3.
22. Ghasemzadeh M.B., Sharma S., Surmeier D.J., Eberwine J.H., Chesselet M.F. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol. Pharmacol. 49:1996;852-859.
23. Gotz T., Kraushaar U., Geiger J., Lubke J., Berger T., Jonas P. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J. Neurosci. 17:1997;204-215.
24. Greenamyre J.T. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology. Funct. Neurology. 15:2000;67-80. "Ottorino Rossi" Award 2000.
25. Gross C.E., Boraud T., Guehl D., Bioulac B., Bezard E. From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research? Prog. Neurobiol. 59:1999;509-532.
26. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
27. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
28. Jarvis C.R., Xiong Z.G., Plant J.R., Churchill D., Lu W.Y., MacVicar B.A., MacDonald J.F. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons. J. Neurophysiol. 78:1997;2363-2371.
29. Jelitai M., Schlett K., Varju P., Eisel U., Madarasz E. Regulated appearance of NMDA receptor subunits and channel functions during in vitro neuronal differentiation. J. Neurobiol. 51:2002;54-65.
30. Jellinger K.A. Recent developments in the pathology of Parkinson's disease. J. Neural Transm., Suppl. 2002;347-376.
31. Jouanen A., Tremblet A.M., Massardier D., Haesslein J.L., Hunt P.F. GABA release from mouse striatal neurons in primary culture as a test for the functional activity of N-methyl-D-aspartate (NMDA) antagonists. J. Neurosci. Methods. 36:1991;27-32.
32. Komuro H., Rakic P. Modulation of neuronal migration by NMDA receptors. Science. 260:1993;95-97.
33. Kovacs A.D., Cebers G., Cebere A., Moreira T., Liljequist S. Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity. Exp. Neurol. 168:2001;47-62.
34. Lafon-Cazal M., Viennois G., Kuhn R., Malitschek B., Pin J.P., Shigemoto R., Bockaert J. mGluR7-like receptor and GABA(B) receptor activation enhance neurotoxic effects of N-methyl-D-aspartate in cultured mouse striatal GABAergic neurones. Neuropharmacology. 38:1999;1631-1640.
35. Lai S.K., Wong C.K.C., Yang M.S., Yung K.K.L. Changes in expression of N-methyl-D-aspartate receptor subunits in the rat neostriatum after a single dose of antisense oligonucleotide specific for N-methyl-D-aspartate receptor one subunit. Neuroscience. 98:2000;493-500.
36. Landberg G., Tan E.M., Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp. Cell Res. 187:1990;111-118.
37. Lau W.K., Yeung C.W., Lui P.W., Cheung L.H., Poon N.T., Yung K.K.L. Different trends in modulation of NMDAR1 and NMDAR2B gene expression in cultured cortical and hippocampal neurons after lead exposure. Brain Res. 932:2002;10-24.
38. Lau W.K., Lui P.W., Wong C.K.C., Chan Y.S., Yung K.K.L. Differential expression of N-methyl-D-aspartate receptor subunit messenger ribonucleic acids and immunoreactivity in the rat neostriatum during postnatal development. Neurochem. Int. 43:2003;47-65.
39. Le D.A., Lipton S.A. Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging. Drugs Aging. 18:2001;717-724.
40. Lotharius J., Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev., Neurosci. 3:2002;932-942.
41. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature. 357:1992;70-74.
42. Misra C., Brickley S.G., Wyllie D.J., Cull-Candy S.G. Slow deactivation kinetics of NMDA receptors containing NR1 and NR2D subunits in rat cerebellar Purkinje cells. J. Physiol. 525(Pt. 2):2000;299-305.
43. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
44. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
45. Morelli M. Dopamine/glutamate interaction as studied by combining turning behaviour and c-Fos expression. Neurosci. Biobehav. Rev. 21:1997;505-509.
46. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:1991;31-37.
47. Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., Yamaguchi S., Kawabata S., Okada M. Glutamate receptors: brain function and signal transduction. Brain Res. Rev. 26:1998;230-235.
48. Nansen E.A., Jokel E.S., Lobo M.K., Micevych P.E., Ariano M.A., Levine M.S. Striatal ionotropic glutamate receptor ontogeny in the rat. Dev. Neurosci. 22:2000;329-340.
49. Aα1 receptor immunoreactivity in the rat substantia nigra. Neuroscience. 99:2000;65-76.
50. BR2 receptor immunoreactivity in neurochemically identified neurons of the rat neostriatum. J. Comp. Neurol. 433:2001;458-470.
51. Novelli A., di Porzio U. Excitatory amino acid response in cultured rat striatal neurons results in a developmentally regulated cGMP formation. Int. J. Dev. Neurosci. 11:1993;425-434.
52. Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S., Sucher N.J., Heinemann S.F. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J. Neurosci. 21:2001;1228-1237.
53. Portera-Cailliau C., Price D.L., Martin L.J. N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J. Neurochem. 66:1996;692-700.
54. Rajadhyaksha A., Barczak A., Macias W., Leveque J.C., Lewis S.E., Konradi C. L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19:1999;6348-6359.
55. Riva M.A., Tascedda F., Molteni R., Racagni G. Regulation of NMDA receptor subunit mRNA expression in the rat brain during postnatal development. Mol. Brain Res. 25:1994;209-216.
56. Scheetz A.J., Constantine-Paton M. Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J. 8:1994;745-752.
57. Shimoda K., Sauve Y., Marini A., Schwartz J.P., Commissiong J.W. A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell culture. Brain Res. 586:1992;319-331.
58. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience. 86:1998;353-387.
59. Standaert D.G., Testa C.M., Young A.B., Penney J.B. Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol. 343:1994;1-16.
60. Standaert D.G., Friberg I.K., Landwehrmeyer G.B., Young A.B., Penney J.B. Jr. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Mol. Brain Res. 64:1999;11-23.
61. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neurosci. 15:1995;6509-6520.
62. Sun L., Margolis F.L., Shipley M.T., Lidow M.S. Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor: its regional distribution and developmental expression in the rat brain. FEBS Lett. 441:1998;392-396.
63. Sun L., Shipley M.T., Lidow M.S. Expression of NR1, NR2A-D, and NR3 subunits of the NMDA receptor in the cerebral cortex and olfactory bulb of adult rat. Synapse. 35:2000;212-221.
64. Sze S.C.W., Wong C.K.C., Yung K.K.L. Modulation of the gene expression of N-methyl-D-aspartate receptor NR2B subunit in the rat neostriatum by a single dose of specific antisense oligodeoxynucleotide. Neurochem. Int. 39:2001;319-327.
65. Tepper J.M., Trent F. In vivo studies of the postnatal development of rat neostriatal neurons. Arbuthnott G.W., Emson P.C. Chemical Signaling in the Basal Ganglia. vol.99:1993;35-50 Elsevier, New York.
66. Tepper J.M., Sharpe N.A., Koos T.Z., Trent F. Postnatal development of the rat neostriatum: electrophysiological, light- and electron-microscopic studies. Dev. Neurosci. 20:1998;125-145.
67. Tse Y.C., Yung K.K.L. Cellular expression of ionotropic glutamate receptor subunits in subpopulations of neurons in the rat substantia nigra pars reticulata. Brain Res. 854:2000;57-69.
68. Vicini S., Rumbaugh G. A slow NMDA channel: in search of a role. J. Physiol. 525(Pt. 2):2000;283.
69. Vincent S.R., Sebben M., Dumuis A., Bockaert J. Neurotransmitter regulation of MAP kinase signaling in striatal neurons in primary culture. Synapse. 29:1998;29-36.
70. Wong H.K., Liu X.B., Matos M.F., Chan S.F., Perez-Otano I., Boysen M., Cui J., Nakanishi N., Trimmer J.S., Jones E.G., Lipton S.A., Sucher N.J. Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J. Comp. Neurol. 450:2002;303-317.
71. Yoshioka A., Ikegaki N., Williams M., Pleasure D. Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. J. Neurosci. Res. 46:1996;164-178.
72. Yung K.K.L., Tang F., Vacca-Galloway L.L. Decrease of enkephalins in cerebellum during Wobbler mouse motoneuron disease. Brain Res. 599:1992;175-180.
73. BR1 receptor immunoreactivity. Brain Res. 830:1999;345-352.
74. Yurek D.M., Sladek J.R. Dopamine cell replacement: Parkinson's disease. Annu. Rev. Neurosci. 13:1990;415-440.
75. Zhong J., Carrozza D.P., Williams K., Pritchett D.B., Molinoff P.B. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J. Neurochem. 64:1995;531-539.